DE69922498D1 - Fluorescierende Cyaninlabels mit einem Sulphamidobrückenglied - Google Patents

Fluorescierende Cyaninlabels mit einem Sulphamidobrückenglied

Info

Publication number
DE69922498D1
DE69922498D1 DE1999622498 DE69922498T DE69922498D1 DE 69922498 D1 DE69922498 D1 DE 69922498D1 DE 1999622498 DE1999622498 DE 1999622498 DE 69922498 T DE69922498 T DE 69922498T DE 69922498 D1 DE69922498 D1 DE 69922498D1
Authority
DE
Germany
Prior art keywords
sub
group
indipendently
alkylensulfonic
alkylensulfonate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE1999622498
Other languages
English (en)
Other versions
DE69922498T2 (de
Inventor
Giuseppe Caputo
Ciana Leopoldo Della
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Visen Medical Inc
Original Assignee
Visen Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Visen Medical Inc filed Critical Visen Medical Inc
Application granted granted Critical
Publication of DE69922498D1 publication Critical patent/DE69922498D1/de
Publication of DE69922498T2 publication Critical patent/DE69922498T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
    • C09B23/02—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
DE69922498T 1999-07-02 1999-07-02 Fluorescierende Cyaninlabels mit einem Sulphamidobrückenglied Expired - Lifetime DE69922498T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99112696A EP1065250B1 (de) 1999-07-02 1999-07-02 Fluorescierende Cyaninlabels mit einem Sulphamidobrückenglied

Publications (2)

Publication Number Publication Date
DE69922498D1 true DE69922498D1 (de) 2005-01-13
DE69922498T2 DE69922498T2 (de) 2005-12-08

Family

ID=8238492

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69922498T Expired - Lifetime DE69922498T2 (de) 1999-07-02 1999-07-02 Fluorescierende Cyaninlabels mit einem Sulphamidobrückenglied
DE69941067T Expired - Lifetime DE69941067D1 (de) 1999-07-02 1999-07-02 Fluoreszierende Cyaninlabels mit einem Sulphamidobrückenglied

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69941067T Expired - Lifetime DE69941067D1 (de) 1999-07-02 1999-07-02 Fluoreszierende Cyaninlabels mit einem Sulphamidobrückenglied

Country Status (8)

Country Link
US (1) US6448008B1 (de)
EP (2) EP1491591B1 (de)
AT (2) ATE284433T1 (de)
AU (1) AU776841B2 (de)
BR (1) BR0005843A (de)
CA (1) CA2312099C (de)
DE (2) DE69922498T2 (de)
ES (1) ES2329572T3 (de)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001288197A (ja) * 2000-04-10 2001-10-16 Fuji Photo Film Co Ltd 蛍光ヌクレオチド
US7597878B2 (en) * 2000-09-19 2009-10-06 Li-Cor, Inc. Optical fluorescent imaging
EP1770129B1 (de) 2000-09-29 2012-07-25 Life Technologies Corporation Modifizierte Carbocyaninfarbstoffe und deren Konjugate
DE60126297T2 (de) 2000-09-29 2007-11-15 Molecular Probes, Inc., Eugene Modifizierte carbocyaninfarbstoffe und deren konjugate
US20050069962A1 (en) 2001-10-12 2005-03-31 Archer Robert M Antibody complexes and methods for immunolabeling
US8323903B2 (en) 2001-10-12 2012-12-04 Life Technologies Corporation Antibody complexes and methods for immunolabeling
WO2003057175A2 (en) 2002-01-02 2003-07-17 Visen Medical, Inc. Amine functionalized superparamagnetic nanoparticles for the synthesis of bioconjugates and uses therefor
AU2003225763A1 (en) * 2002-03-11 2003-09-29 Visen Medical, Inc. Optical imaging probes
AU2003237185A1 (en) * 2002-05-07 2003-11-11 The Research Foundation Of State University Of New York A method to rapidly prepare and screen formulations and compositions containing same
US7172907B2 (en) * 2003-03-21 2007-02-06 Ge Healthcare Bio-Sciences Corp. Cyanine dye labelling reagents with meso-substitution
US20080102036A1 (en) * 2003-06-04 2008-05-01 Poss Kirtland G Biocompatible Fluorescent Silicon Nanoparticles
US7282339B2 (en) 2003-09-17 2007-10-16 Invitrogen Corporation Competitive immunoassay
WO2006020947A2 (en) 2004-08-13 2006-02-23 Epoch Biosciences, Inc. Phosphonate fluorescent dyes and conjugates
US7569695B2 (en) * 2005-05-24 2009-08-04 Enzo Life Sciences, Inc. Dyes for the detection or quantification of desirable target molecules
US8357801B2 (en) 2005-05-24 2013-01-22 Enzo Life Sciences, Inc. Labeling of target molecules, identification of organelles and other applications, novel compositions, methods and kits
US7737281B2 (en) * 2005-05-24 2010-06-15 Enzo Life Sciences, Inc. C/O Enzo Biochem, Inc. Purine based fluorescent dyes
US9574085B2 (en) * 2005-09-02 2017-02-21 Visen Medical, Inc. Biocompatible N, N-disubstituted sulfonamide-containing fluorescent dye labels
US8173819B2 (en) 2005-09-02 2012-05-08 Visen Medical, Inc. Nicotinic and picolinic acid derived near-infrared fluorophores
EP1937676B1 (de) * 2005-09-02 2016-11-30 Visen Medical, Inc. Biologisch kompatible, fluoreszente mittel zur bilddarstellung
ES2434491T3 (es) 2005-10-13 2013-12-16 Funda��O D. Anna Sommer Champalimaud E Dr. Carlos Montez Champalimaud An�lisis inmunohistoqu�mico multiplex in situ
ATE500778T1 (de) 2005-12-22 2011-03-15 Visen Medical Inc Kombiniertes röntgen- und optisches tomographie- bildgebungssystem
EP1973575B1 (de) 2005-12-22 2019-07-24 Visen Medical, Inc. Biokompatibele fluoreszierende metalloxide nanopartikel
ITSV20060002A1 (it) * 2006-01-19 2007-07-20 Ferrania Technologies Spa Colorante fluorescente di tipo cianinico
WO2007087582A1 (en) 2006-01-24 2007-08-02 Invitrogen Corporation Device and methods for quantifying analytes
DK1987068T3 (en) 2006-02-10 2018-09-03 Life Technologies Corp OLIGOSACCHARID MODIFICATION AND LABELING OF PROTEINS
US8114636B2 (en) 2006-02-10 2012-02-14 Life Technologies Corporation Labeling and detection of nucleic acids
US8562802B1 (en) 2006-02-13 2013-10-22 Life Technologies Corporation Transilluminator base and scanner for imaging fluorescent gels, charging devices and portable electrophoresis systems
MX2008012167A (es) 2006-03-23 2009-01-07 Absorber Ab Antigenos de grupo sanguineo de diferentes tipos para aplicaciones de diagnostico y terapeuticas.
US8623639B2 (en) 2006-04-20 2014-01-07 Becton, Dickinson And Company Thermostable proteins and methods of making and using thereof
EP2118206B9 (de) 2007-02-09 2018-08-29 Visen Medical, Inc. Polycyclofarbstoffe und verwendung davon
US8906354B2 (en) 2007-02-28 2014-12-09 Bruker Biospin Corporation Loaded latex optical molecular imaging probes containing lipophilic large stokes shift dyes
US8017104B2 (en) 2007-02-28 2011-09-13 Carestream Health, Inc. Large stoke shift dye used for optical imaging
WO2008109832A2 (en) * 2007-03-08 2008-09-12 Visen Medical, Inc. Viable near-infrared fluorochrome labeled cells and methods of making and using same
WO2009055095A1 (en) 2007-10-19 2009-04-30 Visen Medical, Inc. Imaging systems featuring waveguiding compensation
EP2244741B1 (de) 2008-01-18 2015-03-25 VisEn Medical, Inc. Fluoreszierende bildgebungsmittel
WO2009114776A2 (en) 2008-03-14 2009-09-17 Visen Medical, Inc. Integrin targeting agents and methods of using same
CN102119223A (zh) 2008-05-16 2011-07-06 生命技术公司 用于测量细胞增殖的双标记法
US8864821B2 (en) 2008-11-26 2014-10-21 Visen Medical, Inc. Methods and compositions for identifying subjects at risk of developing stent thrombosis
US20110021908A1 (en) 2009-05-27 2011-01-27 Lumicell Diagnostics, Inc. Methods and systems for spatially identifying abnormal cells
US9155471B2 (en) 2009-05-27 2015-10-13 Lumicell, Inc'. Methods and systems for spatially identifying abnormal cells
CA2809798C (en) 2009-08-28 2018-09-18 Visen Medical, Inc. Systems and methods for tomographic imaging in diffuse media using a hybrid inversion technique
EP2473563B1 (de) 2009-08-31 2019-06-19 Promega Corporation Reaktive cyaninverbindungen
CN102781307B (zh) 2009-09-22 2016-01-20 文森医学公司 用于漫射性介质虚拟折射率匹配的系统和方法
CN101747655B (zh) * 2009-12-24 2013-04-03 渤海大学 含薁类结构水溶性菁染料及其合成方法
WO2012022734A2 (en) 2010-08-16 2012-02-23 Medimmune Limited Anti-icam-1 antibodies and methods of use
US9314304B2 (en) 2010-12-08 2016-04-19 Lumicell, Inc. Methods and system for image guided cell ablation with microscopic resolution
CN110204478A (zh) * 2011-05-09 2019-09-06 文森医学公司 碳酸酐酶靶向剂及其使用方法
US9375493B2 (en) 2012-03-30 2016-06-28 Visen Medical, Inc. Bacterial imaging agents and methods of using same
JP6370785B2 (ja) 2012-08-15 2018-08-08 ビセン メディカル， インコーポレイテッド 前立腺がんイメージングのための前立腺特異的抗原薬剤およびその使用方法
WO2014062716A1 (en) 2012-10-15 2014-04-24 Visen Medical, Inc. Systems, methods, and apparatus for imaging of diffuse media featuring cross-modality weighting of fluorescent and bioluminescent sources
EP2912459A2 (de) 2012-10-25 2015-09-02 Life Technologies Corporation Verfahren und zusammensetzungen zur enzymvermittelten stellenspezifischen radioaktiven markierung von glykoproteinen
CA2902982C (en) * 2013-03-08 2020-08-04 Illumina Cambridge Ltd Polymethine compounds and their use as fluorescent labels
EP2967280A4 (de) 2013-03-14 2016-09-28 Lumicell Inc Medizinische bildgebungsvorrichtung und verfahren zur verwendung
EP2970342B1 (de) 2013-03-15 2024-01-24 VisEn Medical, Inc. Substituiertes silaxanthenium-rot für nahinfrarot-fluorchrome zur in-vitro- und in-vivo-bildgebung und -erkennung
WO2014144702A2 (en) 2013-03-15 2014-09-18 Visen Medical, Inc. 4,4-disubstituted cyclohexyl bridged heptamethine cyanine dyes and uses thereof
WO2015050959A1 (en) 2013-10-01 2015-04-09 Yale University Anti-kit antibodies and methods of use thereof
KR102501920B1 (ko) 2013-10-02 2023-02-20 메디뮨 엘엘씨 중화 항-인플루엔자 a 항체 및 이의 용도
US10542918B2 (en) 2013-10-23 2020-01-28 Verily Life Sciences Llc Modulation of a response signal to distinguish between analyte and background signals
US9504405B2 (en) 2013-10-23 2016-11-29 Verily Life Sciences Llc Spatial modulation of magnetic particles in vasculature by external magnetic field
JP5824729B2 (ja) * 2013-12-18 2015-11-25 東洋インキＳｃホールディングス株式会社 カラーフィルタ用着色組成物、およびカラーフィルタ
CN106455979A (zh) 2013-12-31 2017-02-22 纪念斯隆-凯特琳癌症中心 用于荧光源实时多通道成像的系统、方法和设备
KR20170094268A (ko) 2014-12-15 2017-08-17 메모리얼 슬로안-케터링 캔서 센터 향상된 신경-결합 선택성을 갖는 고리형 펩티드, 상기 고리형 펩티드와 결합된 나노입자, 및 실시간 생체내 신경 조직 영상화를 위한 이들의 용도
US9861710B1 (en) 2015-01-16 2018-01-09 Verily Life Sciences Llc Composite particles, methods, and in vivo diagnostic system
US10028659B2 (en) 2015-03-26 2018-07-24 Verily Life Sciences Llc Aptamer-based sensors, implantable devices and detection system
GB201516987D0 (en) 2015-09-25 2015-11-11 Illumina Cambridge Ltd Polymethine compounds and their use as fluorescent labels
AU2016362673A1 (en) * 2015-12-01 2018-06-28 Dishman Carbogen Amcis Limited An improved process for the preparation of indocyanine green
EP3389726A1 (de) 2015-12-15 2018-10-24 Memorial Sloan Kettering Cancer Center Bildgebungssysteme und -verfahren zur differenzierung von gewebe, z.b. zur intraoperativen visualisierung
EP3443126B1 (de) 2016-04-15 2023-11-15 Icahn School of Medicine at Mount Sinai Gewebeprofilierung unter verwendung von multiplexierten immunhistochemischen aufeinanderfolgenden färbungen
RU2637310C1 (ru) * 2016-06-08 2017-12-04 Федеральное Государственное Бюджетное Учреждение Науки Институт Молекулярной Биологии Им. В.А. Энгельгардта Российской Академии Наук (Имб Ран) Флуоресцентно-меченые дезоксиуридинтрифосфаты
WO2018031448A1 (en) 2016-08-11 2018-02-15 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Near-ir light-cleavable conjugates and conjugate precursors
CN110167601A (zh) 2016-11-30 2019-08-23 纪念斯隆凯特琳癌症中心 抑制剂-功能化超微小纳米粒子和其方法
CN110546273A (zh) 2017-03-30 2019-12-06 生命技术公司 通过衔接子序列定量ngs dna
US20220002716A1 (en) 2020-07-02 2022-01-06 Life Technologies Corporation Trinucleotide cap analogs, preparation and uses thereof
EP4015004A1 (de) 2020-12-18 2022-06-22 Phi Pharma SA Proteoglykanspezifische verzweigte peptide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1287000A (fr) * 1961-03-07 1962-03-09 Gevaert Photo Prod Nv Procédé pour la sensibilisation d'émulsions photographiques
US5556959A (en) * 1993-01-22 1996-09-17 Pharmacia P-L Biochemicals Inc. Indocarbocyanine-linked phosphoramidites
US5808044A (en) 1993-01-22 1998-09-15 Pharmacia Biotech Inc. Indocarbocyanine and benzindocarbocyanine phosphoramidites
US5714386A (en) * 1996-01-11 1998-02-03 Board Of Trustees Of The Leland Stanford Junior University Cy7-allophycocyanin conjugates for use in multiplex fluorescence detection assays

Also Published As

Publication number Publication date
ATE435262T1 (de) 2009-07-15
EP1065250A1 (de) 2001-01-03
DE69922498T2 (de) 2005-12-08
EP1491591A1 (de) 2004-12-29
ES2329572T3 (es) 2009-11-27
ATE284433T1 (de) 2004-12-15
DE69941067D1 (de) 2009-08-13
EP1065250B1 (de) 2004-12-08
CA2312099A1 (en) 2001-01-02
AU4258100A (en) 2001-01-11
BR0005843A (pt) 2002-01-02
AU776841B2 (en) 2004-09-23
CA2312099C (en) 2009-05-12
US6448008B1 (en) 2002-09-10
EP1491591B1 (de) 2009-07-01

Similar Documents

Publication Publication Date Title
DE69922498D1 (de) Fluorescierende Cyaninlabels mit einem Sulphamidobrückenglied
BR1101017A (pt) Distamicina a análoga; processo para a apresentação de um composto; composição farmacêutica contendo um composto; e uso de um composto
CA2347512A1 (en) Adenine derivatives
ES2165711T3 (es) Colorantes de trimetina cianina rigidificada.
KR870002127A (ko) 니트로메틸렌 유도체의 제조방법
KR920700202A (ko) 아크릴로일 치환된 피롤 유도체
AR018634A1 (es) Derivados de benzo(b)tiepin-1,1,-dioxido, procedimiento para su preparacion, medicamentos conteniendo estos compuestos, procedimiento para la preparacion de medicamentos y su empleo para la preparacion de medicamentos.
RU94004997A (ru) Производные полизамещенных 2-амидо-4-фенилтиазолов, способ их получения, промежуточные соединения синтеза и фармацевтическая композиция на их основе
KR960014112A (ko) 자외선 흡수제, 이의 제조방법 및 용도
DE69818042D1 (de) Flüssige benzisochinoline derivate
DK0535231T3 (da) Pyrimidinnucleosid-derivater
SE8505716D0 (sv) Novel compounds and conjugates thereof
EA200301317A1 (ru) Производные аминохинолина и его применение в качестве лигандов аденозина a3
KR960017638A (ko) 옥사졸 아민 중간체를 통한 아릴피롤류 살충제의 제조방법
KR930701419A (ko) 예정된 대칭성을 갖는 킬레이트제 제조를 위한 중간체 및 그의 제조 방법
AU7078301A (en) Variolin derivatives as anti-cancer agents
DK0601191T3 (da) Hidtil ukendt tetracyklisk forbindelse
ES2179475T3 (es) Nuevos derivados de la eritromicina, su procedimiento de preparacion ysu aplicacion como medicamentos.
Rosen et al. The Synthesis of Spin Labeled Acetylcholine Analogs
KR960029312A (ko) N-아릴알킬페닐아세트아미드 유도체와 그의 제조방법
KR930702269A (ko) 포스포리파제 a2저해 물질
ES2092962B1 (es) Esteres nitricos de derivados del acido 2-(2,6-dihalofenilamino) fenilacetoxiacetico y sus procedimientos de preparacion.
SE8003317L (sv) Bis(4-demetoxidaunorubicin)dihydrazon-derivat och farmakologiskt acceptabla derivat derav
KR970065509A (ko) 신규한 아미노산 아미드 유도체 및 그의 제조방법
KR930005953A (ko) 리그난, 이의 중간체 및 이러한 중간체의 제조방법

Legal Events

Date Code Title Description
8364 No opposition during term of opposition